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Spontaneous Regression of Pulmonary
and Adrenal Metastases Following
Percutaneous Radiofrequency Ablation of
a Recurrent Renal Cell Carcinoma
The spontaneous regression of metastatic lesions from renal cell carcinoma
(RCC) is extremely rare, but may be encountered following cytoreductive treat-
ments. We report a case of a recurrent RCC with multiple metastatic lesions
which spontaneously regressed after undergoing radiofrequency ablation of the
renal tumor.
he spontaneous regression of metastatic lesions from renal cell carcinoma
(RCC) occurs rarely, but is well known as a surprising event following a
nephrectomy (1-3). The spontaneous regression of metastatic lesions
undergoing are most commonly detected in the lung, but other frequent sites include
the liver, bone, and brain (4). The incidence of spontaneous regression of metastatic
lesions from RCC has been reported as less than 1% of all RCC metastasis cases (5).
Recently, we experienced a case of a patient with a recurrent RCC with multiple
metastatic lesions which spontaneously regressed after a cytoreductive radiofrequency
(RF) ablation of the RCC was performed. We report this case, with an emphasis on the
clinical and imaging features, due to its rare incidence in relation to an RF ablation.
CASE REPORT
The institutional review board approved this case report prior to any review of
medical records. An 80-year-old man was transferred to our institute because of an
incidentally detected renal tumor. The patient underwent a right partial nephrectomy
due to a previously diagnosed RCC eight years prior. Recent routine follow-up CT
images, which covered the lung and abdomen, revealed a right renal mass, a right
adrenal mass, and three pulmonary nodules; all of which were not seen on prior CT
images (Figs. 1A-C). The right renal tumor and adrenal tumor had maximum
diameters measuring 2.0 cm and 1.8 cm, respectively. In addition, the pulmonary
nodules, with maximum diameters ranging from 8 to 10 mm, were seen in the right
upper lobe, left upper lobe, and left lower lobe. The treatment modality decided upon
was an RF ablation for the cytoreductive removal of the right renal tumor. However,
the histological results were not confirmed before the ablation as these lesions were
clinically considered to be recurrent or as metastatic lesions from the previously
removed RCC.
An internally-cooled RF system (Radionics, Burlington, MA) was used for the
ablation of the right renal tumor, along with an electrode (Cool-tip, Valleylab,
Boulder, CO) that was kept below 20。 C by means of chilled water supplied by a
peristaltic pump. We selected an RF electrode with a 2 cm active tip, which
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Fig. 1. 80-year-old man with multiple metastatic lesions from previously removed renal cell carcinoma.
A. Pre-ablation abdomen CT shows well-enhancing solid tumor (arrows) arising from site of previous partial nephrectomy, which
suggests recurrent renal cell carcinoma.
B. Chest CT, which was performed prior to radiofrequency ablation, shows well-defined metastatic nodule in right upper lobe of lung
(arrow). Lesion has maximum diameter of 10 mm.
C. Pre-ablation abdomen CT shows well-enhancing tumor (arrow) arising from right adrenal gland. Lesion has maximum diameter of 1.8
cm. CT image was obtained in supine position of patient.
D. Post-ablation abdomen CT performed 10 months after radiofrequency ablation shows lack of tumor enhancement within tumor, which
suggests complete ablation (arrows). 
E. Chest CT performed 10 months after radiofrequency ablation reveals that nodule (arrow) is significantly reduced and maximum
diameter cannot be measured.
F. Post-ablation abdomen CT shows that right adrenal mass (arrow) decreases to one-half volume (1.4-cm maximum diameter). This CT
image was obtained in prone position of patient.
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corresponded to the size of the right renal tumor. The
electrode was appropriately targeted in the center of the
renal tumor under ultrasound (US) guidance and
performed two cycles of RF ablation. For the first ablation
cycle, electrical power was delivered at the highest electri-
cal energy for 12 minutes. For the second RF cycle,
reduced electrical power (80 W) was delivered for 3
minutes due to severe pain. For pain relief, a total of 50 mg
of penthidine HCI (Hana Pharmacy Corporation,
Hwasung, Korea) was intravenously infused during the RF
ablation.
A post-ablation CT performed 10 months after the
ablation showed a lack of tumor enhancement within the
right renal tumor (Fig. 1D). The size of the recurrent renal
tumor decreased to a maximum diameter of 1.4 cm. All of
the metastatic pulmonary nodules became too small to be
measured on CT images (Fig. 1E). In addition, the right
adrenal tumor decreased in size to a maximum diameter of
1.4 cm (Fig. 1F). Chemotherapy and immunotherapy was
not performed due to the poor general condition and old
age of the patient. The patient was clinically well for 15
months following the RF ablation.
DISCUSSION
Spontaneous tumor regression has been reported to
occur for some types of malignant tumors, although the
incidence is rare. This phenomenon may be defined when
the tumors partially decrease or totally disappear without
any treatment. An RCC can be a spontaneously regressing
tumor and is in fact known to develop in less than 1% of
RCC cases (1-5).
The pathological mechanism of spontaneous regression is
still unclear. Spontaneous regression of metastatic lesions
from an RCC have occurred frequently following a
nephrectomy, radiotherapy, or embolization (1-4, 6). As
with our case, metastatic pulmonary lesions were reported
to spontaneously regress following an RF ablation of a
tumor (7). These cytoreductive treatments seemed to play
a major role in the spontaneous regression; however, the
role of nephrectomy accounted for only less than 50% of
all reported cases with spontaneous regression (4).
Immunological responses to an RCC are also quite contro-
versial, but the use of interferon to strengthen the hosts
immunity, which may ultimately improve the survival of
patients with advanced stage RCC should be performed
(8).
In general, here has been a consensus that an RF ablation
can be used in treating patients with a localized RCC,
which is difficult to remove surgically. Recently, this
treatment modality has been considered as a good alterna-
tive treatment option because of its minimally invasive
nature and excellent clinical outcome. For this reason, an
RF ablation might be as beneficial as a nephrectomy at
inducing the spontaneous regression of RCC, although
their mechanisms are unknown. Both the RF ablation and
a nephrectomy may be involved in stimulating the host’s
immune system as if these treatments naturally kill the
cells of RCC as with the use of immnunotherapy using
interferon. A literature search revealed that our case was
found to be the second case report on the spontaneous
regression of pulmonary metastases following an RF
ablation of the recurrent RCC (7). However, we could not
find any cases with spontaneous regression of adrenal
metastasis from the RCC following ablation. The RF
ablation might be recommended as a good alternative
treatment when a cytoreductive nephrectomy is required
in patients with metastatic lesions, but are in poor general
physical condition.
In conclusion, spontaneous regression of metastatic
lesions from an RCC is extremely rare, but can result
following the RF ablation of the tumor.
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